Literature DB >> 23026399

Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia T-cells.

Patrick J Cimino1, David W Bahler, Eric J Duncavage.   

Abstract

Chronic lymphocytic leukemia/small cell lymphoma (CLL/SLL) is the most common B-cell leukemia/lymphoma, effecting >15,000 patients/year. There has been a proposed limited antigenic etiology, at least in some cases, of CLL/SLL based upon immunoglobulin heavy chain stereotypy found across unrelated cases, suggesting viral source may provide such antigenic stimulation. With an established epidemiological link between CLL/SLL and Merkel cell carcinoma (MCC), there has been some interest in investigating a possible leukemogenic role of Merkel cell polyomavirus (MCPyV), which is found in 80% of MCC cases. Recent studies have shown that MCPyV is present in lymphocytes in a small percentage of CLL/SLL cases, but the specific tropism for lymphocytes has not been well-established. In this study, we used quantitative PCR to investigate the presence of MCPyV in fluorescence activated cell sorted purified B- and T-cells from 23 CLL/SLL cases. Three of 23 cases (13%) had detectable MCPyV in T-cells, and none of the cases had detectable MCPyV in B-cells. These findings suggest that MCPyV may have tropism for T-cells in addition to previously reported neoplastic B-cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026399     DOI: 10.1016/j.yexmp.2012.09.019

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  2 in total

1.  The role of the immune response in merkel cell carcinoma.

Authors:  Pierre L Triozzi; Anthony P Fernandez
Journal:  Cancers (Basel)       Date:  2013-02-28       Impact factor: 6.639

2.  RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.

Authors:  Sonja Hesbacher; Lisa Pfitzer; Katharina Wiedorfer; Sabrina Angermeyer; Andreas Borst; Sebastian Haferkamp; Claus-Jürgen Scholz; Marion Wobser; David Schrama; Roland Houben
Journal:  Oncotarget       Date:  2016-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.